Skip to main content
Watch Insiders
Market intelligence
CGTXHealthcare

Cognition Therapeutics Inc insider activity

In the last 90 days, 3 corporate insiders purchased $32,493 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
3
90-day purchase value
$32,493
Corporate buyers
3
Latest transaction
Apr 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 16, 2026John Brendan DoyleChief Financial OfficerOpen Market Purchase10,000$1.13$11,300
Apr 16, 2026Lisa RicciardiCEO & PresidentOpen Market Purchase9,175$1.10$10,093
Apr 16, 2026Anthony CaggianoChief Medical OfficerOpen Market Purchase10,000$1.11$11,100